Rising hypertension prevalence, cardiovascular risk awareness, and the need for routine monitoring are increasing demand for accurate blood pressure measurement solutions. Healthcare providers are adopting automated and connected devices to improve screening, diagnosis, and long-term patient monitoring. Home-based testing is also gaining momentum as healthcare delivery shifts toward preventive and remote care models.
The Blood Pressure Test Market is projected to expand from US$2.06 billion in 2025 to US$6.5 billion by 2034, registering a 13.60% CAGR from 2026 to 2034. Growth is supported by the increasing burden of hypertension, cardiovascular diseases, and renal disorders, alongside greater adoption of automated monitoring devices across hospitals, diagnostic centers, and homecare settings. The transition toward connected healthcare and remote patient monitoring is further strengthening demand for digitally enabled blood pressure testing solutions.
Get Sample PDF @ https://www.theinsightpartners.com/sample/TIPRE00020477
Rising Hypertension Burden Drives Demand
Hypertension remains a major contributor to cardiovascular complications and requires regular measurement for effective disease management. Increasing awareness of early diagnosis is encouraging healthcare systems to incorporate blood pressure testing into routine primary care, pharmacy screening, chronic disease programs, and preventive health assessments.
The growing prevalence of diabetes, obesity, kidney disease, and coronary heart disease is also expanding the need for repeated blood pressure measurements. Unlike one-time diagnostic procedures, blood pressure monitoring generates recurring demand for devices, cuffs, accessories, and replacement components. This creates a sustainable growth environment for manufacturers offering accurate, validated, and user-friendly solutions.
Technology Shift Toward Automated and Connected Devices
Technological advancements are transforming blood pressure testing from basic measurement toward connected cardiovascular monitoring. Automated upper-arm monitors are increasingly preferred because they simplify operation and reduce user-dependent measurement errors. Manufacturers are incorporating Bluetooth connectivity, larger displays, memory storage, cuff-fit detection, arrhythmia alerts, and smartphone integration.
Connected devices are particularly relevant to remote patient monitoring programs. Patients can record readings at home and share longitudinal data with healthcare professionals, supporting treatment adjustments between consultations. Algorithms designed to reduce errors associated with movement, improper cuff positioning, and irregular heart rhythms are also improving device performance.
Homecare Settings and Remote Monitoring Create Opportunities
Homecare settings represent one of the fastest-growing end-user areas, supported by increasing acceptance of self-measured blood pressure and telehealth. Home monitoring can help identify white-coat and masked hypertension while providing clinicians with a broader set of readings than occasional office measurements.
Hospitals and clinics remain major users because blood pressure measurement is embedded in triage, inpatient monitoring, outpatient consultations, anesthesia, and chronic disease management. Diagnostic centers are also expanding their use of automated devices for preventive screening and cardiovascular risk assessments.
From a regional perspective, Asia Pacific is expected to record the fastest growth, with a projected CAGR of 15.2% to 15.9% between 2026 and 2034. China, Japan, India, and South Korea are key contributors. North America remains a structurally advanced region, supported by remote monitoring programs, high diagnosis rates, and connected device penetration.
Competitive Landscape and Product Segmentation
Competition is intensifying as established medical device manufacturers and consumer healthcare companies expand their portfolios. Key companies analyzed include:
- OMRON Healthcare Co., Ltd.
- SunTech Medical, Inc.
- Koninklijke Philips N.V.
- GE HealthCare Technologies Inc.
- Withings SA
- A&D Company Limited
- Microlife Corporation
- Welch Allyn, Inc.
- Spacelabs Healthcare LLC
- SCHILLER AG
- Bosch + Sohn GmbH u. Co. KG
- Jiangsu Yuyue Medical Equipment & Supply Co., Ltd.
- Andon Health Co., Ltd.
- Nihon Seimitsu Sokki Co., Ltd.
By product, sphygmomanometers held the largest share in 2025, accounting for approximately 41% to 45%, owing to their extensive clinical and homecare use. Blood pressure transducers remain important in intensive care and operating-room environments, while instruments and accessories benefit from recurring replacement requirements.
By indication, hypertension represents the dominant application, while coronary heart disease supports increasing demand for regular cardiovascular monitoring. Among end users, hospitals and clinics remain significant revenue contributors, while homecare settings are expected to witness faster adoption as self-monitoring becomes integrated into chronic disease management.
Future Outlook
The future of the Blood Pressure Test Market will be shaped by connected monitoring, AI-assisted signal interpretation, remote patient management, and improved device usability. Manufacturers are expected to focus on validated algorithms, cuff-fit accuracy, multi-size cuffs, intuitive interfaces, and integration with electronic health records and digital health platforms.
Related Report:
1) Micro-Invasive Glaucoma Implants Market Size, Demand & Growth by 2034
2) Surgical Pliers Market Drivers, Trends, and Forecasts by 2031
3) Medical Retractors Market Outlook, Segments, Recent Developments, and Insights by 2031
About Us -
The Insight Partners provides comprehensive syndicated and tailored market research services in the healthcare, technology, and industrial domains. Renowned for delivering strategic intelligence and practical insights, the firm empowers businesses to remain competitive in ever-evolving global markets.
Contact Us:
Ankit Mathur | The Insight Partners
E-mail: ankit.mathur@theinsightpartners.com
Phone: +1-646-491-9876
Also Available in : Korean German Japanese French Chinese Italian Spanish